These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30050877)

  • 41. Proteomic dataset: Profiling of membrane fraction of
    Bukato O; Pobeguts O; Rakitina D; Baikova J; Butenko I; Silantyev A; Fisunov G; Govorun V
    Data Brief; 2019 Dec; 27():104417. PubMed ID: 31687427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of the STAT5-cyclin D/CDK4-pRb pathway in β-cell proliferation stimulated by prolactin during pregnancy.
    Zhao X; Xu Y; Wu Y; Zhang H; Shi H; Zhu H; Woo M; Wu X
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E135-E144. PubMed ID: 30512986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases.
    Franzè E; Caruso R; Stolfi C; Sarra M; Cupi ML; Ascolani M; Sedda S; Antenucci C; Ruffa A; Caprioli F; MacDonald TT; Pallone F; Monteleone G
    Inflamm Bowel Dis; 2013 Mar; 19(3):501-11. PubMed ID: 23429442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disruption of the Hedgehog signaling pathway in inflammatory bowel disease fosters chronic intestinal inflammation.
    Buongusto F; Bernardazzi C; Yoshimoto AN; Nanini HF; Coutinho RL; Carneiro AJV; Castelo-Branco MT; de Souza HS
    Clin Exp Med; 2017 Aug; 17(3):351-369. PubMed ID: 27655445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
    Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
    Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents.
    Lu K; Shih C; Teicher BA
    Cancer Chemother Pharmacol; 2000; 46(4):293-304. PubMed ID: 11052627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy.
    Martinez JC; Palomino JC; Samaniego R; Sepulveda JM; Cabello A; Ricoy JR
    Cancer; 2008 Jul; 113(1):166-74. PubMed ID: 18459177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism underlying the significant role of the miR-4262/SIRT1 axis in children with inflammatory bowel disease.
    Deng X; Shang L; Du M; Yuan L; Xiong L; Xie X
    Exp Ther Med; 2020 Sep; 20(3):2227-2235. PubMed ID: 32765699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL-6 in Crohn's disease.
    Soufflet F; Biraud M; Rolli-Derkinderen M; Lardeux B; Trang C; Coron E; Bruley des Varannes S; Bourreille A; Neunlist M
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28857361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
    Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The evaluation of the biological behavior and grade among cases with mantle cell lymphoma.
    Hashimoto Y; Nakamura N; Kuze T; Abe M
    Leuk Lymphoma; 2002 Mar; 43(3):523-30. PubMed ID: 12002755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of interleukin-17 on gene expression profile of fibroblasts from Crohn's disease patients.
    Kerami Z; Duijvis NW; Vogels EW; van Dooren FH; Moerland PD; Te Velde AA
    J Crohns Colitis; 2014 Oct; 8(10):1208-16. PubMed ID: 24637010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of the prostaglandin D2 metabolic pathway in Crohn's disease: involvement of the enteric nervous system.
    Le Loupp AG; Bach-Ngohou K; Bourreille A; Boudin H; Rolli-Derkinderen M; Denis MG; Neunlist M; Masson D
    BMC Gastroenterol; 2015 Sep; 15():112. PubMed ID: 26338799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of silencing AEG-1 with small interfering RNA on the proliferation and cell cycle of gastric carcinoma SGC-7901 cells].
    Zhang CF; Xia YH; Zheng QF; Li ZJ; Guo XH; Zhou HC; Zhang LL; Dong LP; Han Y; Liu ZE; Wang WJ; Luo YL
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):22-7. PubMed ID: 23648295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.